US recommends pausing use of J&J's COVID-19 vaccine over blood clot reports

CGTN
The US FDA and the US CDC recommended a pause in use of Johnson & Johnson's COVID-19 vaccine over "six reported cases of a rare & severe type of blood clot."
CGTN

The US Food and Drug Administration (FDA) and the US Centers for Disease Control and Prevention (CDC) recommended a pause in use of Johnson & Johnson's COVID-19 vaccine over "six reported cases of a rare & severe type of blood clot.”

Special Reports
Top